Products - Older people | Topic | NICE

Showing 5 products

Date | Title

Guidance programme: Technology appraisal guidanceRemove ‘Guidance programme: Technology appraisal guidance’ filter
Status: PublishedRemove ‘Status: Published’ filter

Bevacizumab gamma for treating wet age-related macular degeneration (TA1022)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
4 December 2024
Ranibizumab and pegaptanib for the treatment of age-related macular degeneration (TA155)
Product type:
Guidance
Programme:
Technology appraisal guidance
Last updated:
20 May 2024
Published:
27 August 2008
Faricimab for treating wet age-related macular degeneration (TA800)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
29 June 2022
Brolucizumab for treating wet age-related macular degeneration (TA672)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
3 February 2021
Aflibercept solution for injection for treating wet age‑related macular degeneration (TA294)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
24 July 2013